Funded Tech Companies

Enlaza Therapeutics

Looking for the VC firms that provided funding to Enlaza Therapeutics? Amgen Ventures, Regeneron Pharmaceuticals and Alexandria Venture Investments put venture money into this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Enlaza is creating a groundbreaking new class of protein therapeutics that deliver more efficacious and safer treatments for patients. Enlaza's breakthrough War-LockTM technology enables generation of unique, highly-selective biologic drugs that are engineered to become warheads with the capacity to irreversibly lock to disease related targets. We leverage our novel synthetic biology platform, coupled with proprietary amino acids, to precision-engineer biological medicines with improved efficacy and safety profiles.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/30/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Sergio Duron

        

Chief Scientific Officer

Analeah Heidt

        

Co-Founder

Sanford Madigan

        

Vice President

Sergio Duron

        

Vice President

Emily Rowell

        

Company Investors

• Amgen Ventures
• Regeneron Pharmaceuticals
• Alexandria Venture Investments
• JPMorgan Partners
• Lightspeed Venture Partners
• Pappas Capital
• Frazier Life Sciences
• Bregua
• Avalon Ventures
• Samsara BioCapital

Browse more funded tech companies:

Enlaye | Enlibrium

Share this article

About Our Venture Capital Transactions Database

The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary